Achaogen Obtains $56,000,000 Series C Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    7000 Shoreline Court South San Francisco, CA 94080
  • Company Description
    Achaogen specializes in the discovery and development of small molecules to treat infections caused by bacterial infection, and by antibiotic-resistant strains in particular.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series C
  • Proceeds Purposes
    Our mission is to discover and develop life-saving antibiotics. This financing together with non-dilutive capital that we have secured through partnerships with various government agencies will enable us to advance multiple clinical programs, including conducting a Phase 2 study in complicated urinary tract infections of ACHN-490, our lead candidate for multi-drug resistant bacterial infections.
  • M&A Terms
  • Venture Investor
    Frazier Healthcare Ventures
  • Venture Investor
    Alta Partners
  • Venture Investor
    5AM Ventures
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    Domain Associates
  • Venture Investor
  • Venture Investor
    Versant Ventures
  • Venture Investor

Trending on Xconomy